Bio-Techne (TECH)

The company operates through two main business areas: Protein Sciences and Diagnostics and Genomics. Protein Sciences is the larger segment and includes reagents, antibodies, proteins, immunoassays, cell analysis tools, and instruments used to study biological pathways and disease mechanisms. These products are important in basic research as well as in drug discovery and development, where scientists need reliable tools to measure proteins, biomarkers, and cellular activity.

Diagnostics and Genomics includes diagnostic reagents, molecular diagnostic products, controls, spatial biology tools, and technologies used in genetic and tissue-based analysis. This part of the business gives Bio-Techne exposure to clinical testing, precision medicine, and advanced research methods that examine gene and protein expression in biological samples.

Bio-Techne sells into a global customer base, with the United States representing its largest market and meaningful contributions from Europe, the Middle East, Africa, the United Kingdom, and Asia-Pacific. Its products are often embedded in customer workflows, which can support recurring demand for consumables alongside instrument placements.

The company is distinctive for combining research-use-only tools with diagnostics-related capabilities. Its performance is linked to life sciences research funding, biopharma activity, diagnostic testing trends, and demand for technologies that support more detailed analysis of disease biology.